Prosecution Insights
Last updated: October 25, 2026

Patterson + Sheridan, L.L.P. - Dexcom

Technology area: Medical Devices & Mechanical Engineering

37 pending office actions • 1 client • 29 examiners • 13 art units • 0 of 37 (0%) have an AI response strategy ready • 28 patents granted in the last 365 days

Analysis

PATTERSON + SHERIDAN, L.L.P. - Dexcom has 38 pending office actions in Medical Devices & Mechanical Engineering and 487 career applications. The active docket represents a substantial response workload, with a broader application base supporting interpretation of the reported results.

The resolved allowance rate is 80.8%, and the average is 5.18 office actions per allowance. The allowance rate indicates that a majority of resolved applications reached allowance, while the action average is the highest reported prosecution-effort measure in this profile set. Practitioners should account for the substantial examination activity associated with matters that ultimately allowed.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=487 apps, methodology: how we score firms)

80.8%
Allowance Rate
n=487
+0.57σ
Allowance Rate (norm)
n=487
5.2
OAs to Allowance
n=181
+0.21σ
OAs to Allow (norm)
n=181
1126 days
Time to Allowance
n=181
+16.7pp
Interview Lift
n=487
58.9%
RCE Rate
n=487
3.1%
Appeal Rate
n=487

Rejection Performance (% of received rejections ultimately overcome)

51.6%
§101 Overcome
n=128
48.0%
§102 Overcome
n=125
58.0%
§103 Overcome
n=207
55.7%
§112 Overcome
n=140

Specialization & Scale

A61B, G16H, Y02A
Top CPC Subclasses
54%
Top-3 CPC Share
n=487
0
Practitioners
n=487
—
Apps / Practitioner
n=487 (min 20)

Portfolio Summary

37
Total Pending OAs
20
Non-Final OAs
17
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
1
Due this week
3
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 7 days (1)Due ≤ 30 days (3)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

27
Hard (73%)
7
Medium (19%)
3
Easy (8%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only5 (14%)
§101 + other13 (35%)
§103 only5 (14%)
§102 only1 (3%)
§112 only2 (5%)
Double-patenting only1 (3%)
Double-patenting + other1 (3%)
Multi-statute (no §101)9 (24%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
4
Information Tech
11% of docket
2
Communications
5% of docket
1
Semiconductors
3% of docket
29
Mechanical / Eng
78% of docket
1
Business / Other
3% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

370 h
Manual time on pending OAs
74 h
Time saved (low, 20%)
130 h
Time saved (mid, 35%)
3.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
JANG, CHRISTIAN Y 3 68.7% +21.0%
PATEL, NIDHI NIRAJ 3 52.9% +47.5%
SHOSTAK, ANDREY 2 52.4% +61.8%
HENSON, DEVIN B 2 65.1% +43.4%
LOPEZ, SEVERO ANTON P 2 34.9% +40.2%
MCCORMACK, ERIN KATHLEEN 2 7.9% +50.0%
BALSECA, FRANKLIN D 1 60.5% +30.2%
SOREY, ROBERT A 1 49.4% +45.3%
KING, CURTIS J 1 68.2% +29.6%
ANYAN, BARBARA BURGESS 1 77.9% -24.1%

Hard Cases (28)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19267232 REMOTE MONITORING OF ANALYTE MEASUREMENTS BALSECA, FRANKLIN D 7d
18538982 CONTINUOUS GLUCOSE MONITORING SYSTEM INSIGHT NOTIFICATIONS SHOSTAK, ANDREY 19d
18636224 SENSING SYSTEMS AND METHODS FOR PROVIDING OPTIMIZED EXERCISE GUIDANCE TO HEALTHY HOSTS AND ATHLETES USING CONTINUOUSLY MONITORED ANALYTE DATA OKONAK, ELIZABETH LOUISE 20d
17743786 Intermittent Monitoring NATNITHITHADHA, NAVIN 22d
18627989 SYSTEM AND METHODS FOR NON-RESPONSIVE SENSOR DETECTION LOPEZ, SEVERO ANTON P 56d
18306074 USER INTERFACES FOR CONTINUOUS GLUCOSE MONITORING JANG, CHRISTIAN Y 60d
19241159 SYSTEM AND METHOD FOR DATA ANALYTICS AND VISUALIZATION SOREY, ROBERT A —
19029581 GLYCEMIC URGENCY ASSESSMENT AND ALERTS INTERFACE SHOSTAK, ANDREY —

Interview Candidates (17)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18627759 SYSTEM AND METHODS FOR PERSONALIZED NON-ENZYME SIGNAL COMPENSATION HENSON, DEVIN B 8d overdue
19267232 REMOTE MONITORING OF ANALYTE MEASUREMENTS BALSECA, FRANKLIN D 7d
18538982 CONTINUOUS GLUCOSE MONITORING SYSTEM INSIGHT NOTIFICATIONS SHOSTAK, ANDREY 19d
18627989 SYSTEM AND METHODS FOR NON-RESPONSIVE SENSOR DETECTION LOPEZ, SEVERO ANTON P 56d
18306074 USER INTERFACES FOR CONTINUOUS GLUCOSE MONITORING JANG, CHRISTIAN Y 60d
19241159 SYSTEM AND METHOD FOR DATA ANALYTICS AND VISUALIZATION SOREY, ROBERT A —
19190241 SYSTEM AND METHOD FOR PROVIDING ALERTS OPTIMIZED FOR A USER KING, CURTIS J —
19029581 GLYCEMIC URGENCY ASSESSMENT AND ALERTS INTERFACE SHOSTAK, ANDREY —

Client Portfolio (1 client)

Client (Assignee)Pending OAs
DexCom 37

Top Art Units

Art UnitApps
379124
26881
36821
26851
24571
24451
24091
36831
28571
37921

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19267232 REMOTE MONITORING OF ANALYTE MEASUREMENTS Dexcom, Inc. BALSECA, FRANKLIN D 2688 §103§112Other Final Rejection 7d Pending Jul 11, 2025
19241159 SYSTEM AND METHOD FOR DATA ANALYTICS AND VISUALIZATION Dexcom, Inc. SOREY, ROBERT A 3682 §101 Non-Final OA — Pending Jun 17, 2025
19190241 SYSTEM AND METHOD FOR PROVIDING ALERTS OPTIMIZED FOR A USER Dexcom, Inc. KING, CURTIS J 2685 §103DP Non-Final OA — Pending Apr 25, 2025
19176047 MACHINE LEARNING TECHNIQUES FOR OPTIMIZED COMMUNICATION WITH USERS OF A SOFTWARE APPLICATION Dexcom, Inc. ANYAN, BARBARA BURGESS 2457 §103 Non-Final OA — Pending Apr 10, 2025
19096929 WIRELESS SETUP AND SECURITY OF A CONTINUOUS ANALYTE SENSOR SYSTEM DEPLOYED IN HEALTHCARE INFRASTRUCTURE Dexcom, Inc. SWEARINGEN, JEFFREY R 2445 DP Non-Final OA — Pending Apr 01, 2025
19052018 NFC Beacons For Bidirectional Communication Between An Electrochemical Sensor And A Reader Device Dexcom, Inc. CERVETTI, DAVID GARCIA 2409 §112Other Final Rejection — Pending Feb 12, 2025
19029581 GLYCEMIC URGENCY ASSESSMENT AND ALERTS INTERFACE Dexcom, Inc. SHOSTAK, ANDREY 3791 §101§102§103§112 Non-Final OA — Pending Jan 17, 2025
18984806 ALERT OPTIMIZATION IN MULTI-RECEIVER ENVIRONMENTS Dexcom, Inc. HOEKSTRA, JEFFREY GERBEN 3791 §101§102 Non-Final OA — Pending Dec 17, 2024
18960126 COMPRESSION EVENT DETECTION FOR CONTINUOUS GLUCOSE MONITORS Dexcom, Inc. ORTEGA, MARTIN NATHAN 3791 §101§102§103 Non-Final OA — Pending Nov 26, 2024
18917685 ANALYTE SENSOR SYSTEM WITH ACTIVE AND PASSIVE ANTENNAS Dexcom, Inc. HENSON, DEVIN B 3791 §102§103§112 Non-Final OA — Pending Oct 16, 2024
18887956 COMMUNICATION TECHNOLOGY FOR ANALYTE MONITORING SYSTEM Dexcom, Inc. LOPEZ, SEVERO ANTON P 3791 §101§102§103 Non-Final OA — Pending Sep 17, 2024
18781805 SYSTEMS AND METHODS FOR DISPLAY DEVICE AND SENSOR ELECTRONICS UNIT COMMUNICATION Dexcom, Inc. JANG, CHRISTIAN Y 3791 §103§112 Non-Final OA — Pending Jul 23, 2024
18771746 WEARABLE APPARATUS FOR CONTINUOUS BLOOD GLUCOSE MONITORING Dexcom, Inc. MESSERSMITH, ERIC J 3791 §103 Non-Final OA — Pending Jul 12, 2024
18744421 SYSTEMS AND METHODS FOR PROCESSING AND TRANSMITTING SENSOR DATA Dexcom, Inc. JANG, CHRISTIAN Y §103§112Other Non-Final OA — Pending Jun 14, 2024
18737684 METHODS AND SYSTEMS FOR DISEASE PREDICTION Dexcom, Inc. PATEL, NIDHI NIRAJ 3791 §101 Final Rejection — Pending Jun 07, 2024
18737642 SYSTEMS AND METHODS FOR DIABETES PREDICTION Dexcom, Inc. PATEL, NIDHI NIRAJ 3791 §101§103 Final Rejection — Pending Jun 07, 2024
18737588 METHODS AND SYSTEMS FOR DISEASE PREDICTION Dexcom, Inc. PATEL, NIDHI NIRAJ 3791 §101 Non-Final OA — Pending Jun 07, 2024
18676457 SYSTEMS AND METHODS FOR TECHNICAL SUPPORT OF CONTINUOUS ANALYTE MONITORING AND SENSOR SYSTEMS Dexcom, Inc. GILLIGAN, CHRISTOPHER L 3683 §103Other Non-Final OA 8d overdue Pending May 28, 2024
18663473 SYSTEMS AND METHODS FOR MULTI-ANALYTE SENSING Dexcom, Inc. MCCORMACK, ERIN KATHLEEN 3791 §102§103 Non-Final OA — Pending May 14, 2024
18642713 SYSTEMS AND METHODS FOR MULTI-ANALYTE SENSING Dexcom, Inc. MCCORMACK, ERIN KATHLEEN 3791 §103 Final Rejection — Pending Apr 22, 2024
18639201 SYSTEMS AND METHODS FOR COMMUNICATING SENSOR DATA BETWEEN COMMUNICATION DEVICES Dexcom, Inc. BARBEE, MANUEL L 2857 §102§103 Final Rejection — Pending Apr 18, 2024
18636224 SENSING SYSTEMS AND METHODS FOR PROVIDING OPTIMIZED EXERCISE GUIDANCE TO HEALTHY HOSTS AND ATHLETES USING CONTINUOUSLY MONITORED ANALYTE DATA Dexcom, Inc. OKONAK, ELIZABETH LOUISE 3792 §101§103§112 Final Rejection 20d Pending Apr 15, 2024
18627759 SYSTEM AND METHODS FOR PERSONALIZED NON-ENZYME SIGNAL COMPENSATION Dexcom, Inc. HENSON, DEVIN B 3791 §103 Final Rejection 8d overdue Pending Apr 05, 2024
18627989 SYSTEM AND METHODS FOR NON-RESPONSIVE SENSOR DETECTION Dexcom, Inc. LOPEZ, SEVERO ANTON P 3791 §101§102§103 Final Rejection 56d Pending Apr 05, 2024
18628303 NEAR-FIELD-COMMUNICATION-BASED POWER CONTROL FOR AN ANALYTE SENSOR SYSTEM Dexcom, Inc. MCDANIEL, TYNESE V 3791 §102§103 Non-Final OA — Pending Apr 05, 2024
18612072 DECISION SUPPORT AND TREATMENT ADMINISTRATION SYSTEMS Dexcom, Inc. PATEL, OM 3791 §101§103 Final Rejection — Pending Mar 21, 2024
18538982 CONTINUOUS GLUCOSE MONITORING SYSTEM INSIGHT NOTIFICATIONS Dexcom, Inc. SHOSTAK, ANDREY 3791 §101§103§112 Final Rejection 19d Pending Dec 13, 2023
18498548 DETERMINING DECISION SUPPORT OUTPUTS USING USER-SPECIFIC ANALYTE LEVEL CRITERIA Dexcom, Inc. HEALY, NOAH MICHAEL 3791 §102§103 Final Rejection — Pending Oct 31, 2023
18306074 USER INTERFACES FOR CONTINUOUS GLUCOSE MONITORING Dexcom, Inc. JANG, CHRISTIAN Y 3791 §103§112 Final Rejection 60d Pending Apr 24, 2023
18173753 SENSING SYSTEMS AND METHODS FOR PROVIDING DECISION SUPPORT AROUND KIDNEY HEALTH AND/OR DIABETES Dexcom, Inc. CERIONI, DANIEL LEE 3791 §101§103§112 Final Rejection — Pending Feb 23, 2023
17974296 Glycemic Impact Prediction For Improving Diabetes Management Dexcom, Inc. HOLTZCLAW, MICHAEL T. 3796 §101§102§103§112 Non-Final OA — Pending Oct 26, 2022
17974290 Behavior Modification Feedback For Improving Diabetes Management Dexcom, Inc. AKOGYERAM II, NICHOLAS A 3686 §101§112 Non-Final OA — Pending Oct 26, 2022
17974299 Ranking Feedback For Improving Diabetes Management Dexcom, Inc. WESTFALL, SARAH ANN 3791 §101§103 Non-Final OA — Pending Oct 26, 2022
17746743 Adaptive Systems for Continuous Glucose Monitoring Dexcom, Inc. HANEY, JONATHAN MICHAEL 3791 §101 Final Rejection — Pending May 17, 2022
17743786 Intermittent Monitoring Dexcom, Inc. NATNITHITHADHA, NAVIN 3791 §101 Final Rejection 22d Pending May 13, 2022
17556822 MEAL AND ACTIVITY LOGGING WITH A GLUCOSE MONITORING INTERFACE Dexcom, Inc. TILLERY, RASHAWN N 2174 §102 Final Rejection 5d overdue Pending Dec 20, 2021
16878454 SYSTEMS, DEVICES AND METHODS FOR ANALYTE MONITORING SYSTEM Dexcom, Inc. YOON, CHANEL J 3791 §112 Non-Final OA 49d overdue Pending May 19, 2020

Managing Patterson + Sheridan, L.L.P. - Dexcom's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Patterson + Sheridan, L.L.P. - Dexcom's patent allowance rate?

80.8% of resolved applications prosecuted by Patterson + Sheridan, L.L.P. - Dexcom were allowed, across 487 applications in USPTO records.

How many office actions does Patterson + Sheridan, L.L.P. - Dexcom average before allowance?

5.18 office actions per allowed application on average.

How many pending office actions does Patterson + Sheridan, L.L.P. - Dexcom have?

37 pending office actions as of October 2026, for 1 client, before 29 examiners in 13 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month